DUL Intrinsic Valuation and Fundamental Analysis - Alnylam Pharmaceuticals Inc

A	Alnylam Pharmaceuticals Inc XETRA:DUL	US
K	Kinross Gold Corp XMUN:KIN2	CA
	Cedar Woods Properties Ltd ASX:CWP	AU
G	Grupa Azoty SA XBER:5PL	PL
C	Chemours Co F:2CU	US
F	Fintech Ecosystem Development Corp NASDAQ:FEXD	US
	Toro Co F:TO2	US
	Simulations Plus Inc NASDAQ:SLP	US
	Immunome Inc NASDAQ:IMNM	US
M	Mizuho Financial Group Inc XMUN:MZ8	JP
K	Knight-Swift Transportation Holdings Inc F:KSX	US
L	London Stock Exchange Group PLC XMUN:LS4C	UK
	Adial Pharmaceuticals Inc NASDAQ:ADIL	US
C	Coles Group Ltd F:2OF	AU

Intrinsic Value

DUL price has not been updated for more than 3 years. This may indicate that the stock has been delisted.

The intrinsic value for Alnylam Pharmaceuticals Inc (DUL) under the Base Case is hidden EUR. Compared with the current market price of 110.36 EUR, the stock appears hidden .

Intrinsic value calculated as an equal blend of DCF

Locked

and Multiples

Locked

Other reference points

Wall St target

€325.04

Do our valuations actually work? See backtest results .

DUL Intrinsic Value

Unlock

Valuation context is not available yet

There is not enough comparable price and intrinsic value history for DUL.

Track Buy Zone

20% below Intrinsic Value

Get notified when the price drops into your buy zone

Intrinsic Value Locked

Current Price €110.36

Margin of Safety 20% Locked

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Alnylam Pharmaceuticals Inc.

Explain Valuation